Variant report
Variant | nsv522500 |
---|---|
Chromosome Location | chr7:16921334-16922249 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ESR1 | chr7:16921401-16921797 | T-47D | breast: | n/a | n/a |
2 | ESR1 | chr7:16921436-16921876 | T-47D | breast: | n/a | n/a |
3 | ESR1 | chr7:16921460-16921759 | T-47D | breast: | n/a | n/a |
4 | FOXA1 | chr7:16921489-16921703 | T-47D | breast: | n/a | n/a |
5 | NR2F2 | chr7:16921432-16921955 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr7:16921510-16921643 | MCF-7 | breast: | n/a | n/a |
7 | ZNF217 | chr7:16921504-16921837 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:16921699-16921749 | AG10803 | skin: | n/a |
2 | chr7:16921699-16921749 | AG04450 | lung: | fetal |
3 | chr7:16921699-16921749 | SK-N-SH | brain: | n/a |
4 | chr7:16921699-16921749 | HepG2 | liver: | n/a |
5 | chr7:16921699-16921749 | HRE | kidney: | n/a |
6 | chr7:16921699-16921749 | HRPEpiC | eye: | n/a |
7 | chr7:16921699-16921749 | HUVEC | blood vessel: | n/a |
8 | chr7:16921699-16921749 | AoSMC | blood vessel: | n/a |
9 | chr7:16921699-16921749 | GM12878 | blood: | n/a |
10 | chr7:16921699-16921749 | ECC-1 | luminal epithelium: | n/a |
11 | chr7:16921699-16921749 | HIPEpiC | eye: | n/a |
12 | chr7:16921699-16921749 | ovcar-3 | ovarian: | n/a |
13 | chr7:16921699-16921749 | AG04449 | skin: | fetal |
14 | chr7:16921699-16921749 | NB4 | blood: | n/a |
15 | chr7:16921699-16921749 | AG09309 | skin: | n/a |
16 | chr7:16921699-16921749 | HEEpiC | esophagus: | n/a |
17 | chr7:16921699-16921749 | SK-N-MC | brain: | n/a |
18 | chr7:16921699-16921749 | MCF-7 | breast: | n/a |
19 | chr7:16921699-16921749 | HPAEpiC | pulmonary alveolar: | n/a |
20 | chr7:16921699-16921749 | LNCaP | prostate: | n/a |
21 | chr7:16921699-16921749 | U87 | brain: | n/a |
22 | chr7:16921699-16921749 | HL-60 | blood: | n/a |
23 | chr7:16921699-16921749 | Hela-S3 | cervix: | n/a |
24 | chr7:16921699-16921749 | HMEC | breast: | n/a |
25 | chr7:16921699-16921749 | Jurkat | blood: | n/a |
26 | chr7:16921699-16921749 | A549 | lung: | n/a |
27 | chr7:16921699-16921749 | NHBE | bronchial: | n/a |
28 | chr7:16921699-16921749 | CMK | blood: | n/a |
29 | chr7:16921699-16921749 | PFSK-1 | brain: | n/a |
30 | chr7:16921699-16921749 | NT2-D1 | testis: | n/a |
31 | chr7:16921699-16921749 | HNPCEpiC | eye: | n/a |
32 | chr7:16921699-16921749 | SKMC | muscle: | n/a |
33 | chr7:16921699-16921749 | H1-hESC | embryonic stem cell: | embryo |
34 | chr7:16921699-16921749 | RPTEC | kidney: | n/a |
35 | chr7:16921699-16921749 | T-47D | breast: | n/a |
36 | chr7:16921699-16921749 | MCF10A-Er-Src | breast: | n/a |
37 | chr7:16921699-16921749 | BE2_C | brain: | n/a |
38 | chr7:16921699-16921749 | ProgFib | skin: | n/a |
39 | chr7:16921699-16921749 | HCT-116 | colon: | n/a |
40 | chr7:16921699-16921749 | PANC-1 | pancreas: | n/a |
41 | chr7:16921699-16921749 | GM12891 | blood: | n/a |
42 | chr7:16921699-16921749 | GM06990 | blood: | n/a |
43 | chr7:16921699-16921749 | SAEC | small airway: | n/a |
44 | chr7:16921699-16921749 | AG09319 | gingival: | n/a |
45 | chr7:16921699-16921749 | GM19239 | blood: | n/a |
46 | chr7:16921699-16921749 | HCF | heart: | n/a |
47 | chr7:16921699-16921749 | NH-A | brain: | n/a |
48 | chr7:16921699-16921749 | K562 | blood: | n/a |
49 | chr7:16921699-16921749 | HCM | heart: | n/a |
50 | chr7:16921699-16921749 | BJ | skin: | n/a |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AGR2-1 | chr7:16921568-16921597 | NONHSAT119307 |
No data |
No data |
Variant related genes | Relation type |
---|---|
AGR3 | TF binding region |
AGR3 | CpG island |
ENSG00000106541 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3735251 | chr7:16921334-16921335 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs569873228 | chr7:16921337-16921338 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs537250902 | chr7:16921342-16921343 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs146045667 | chr7:16921358-16921359 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs571164847 | chr7:16921362-16921363 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs534694286 | chr7:16921399-16921400 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs185175508 | chr7:16921410-16921411 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs574910288 | chr7:16921583-16921584 | Enhancers Weak transcription Active TSS | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs34843281 | chr7:16921590-16921591 | Enhancers Weak transcription Active TSS | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs188771888 | chr7:16921612-16921613 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs35834535 | chr7:16921623-16921624 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs550088920 | chr7:16921639-16921640 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs138327033 | chr7:16921640-16921641 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs140088608 | chr7:16921653-16921654 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs142002461 | chr7:16921655-16921656 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs543640546 | chr7:16921675-16921676 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs537483797 | chr7:16921684-16921685 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs532462665 | chr7:16921690-16921691 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs554527877 | chr7:16921699-16921700 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs540987090 | chr7:16921703-16921704 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs181511949 | chr7:16921738-16921739 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs567688956 | chr7:16921744-16921745 | Enhancers Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs529648987 | chr7:16921781-16921782 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs184860708 | chr7:16921793-16921794 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs569458835 | chr7:16921815-16921816 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs201794778 | chr7:16921908-16921909 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs531000524 | chr7:16921934-16921935 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs150886427 | chr7:16921942-16921943 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs571036063 | chr7:16921951-16921952 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs535299535 | chr7:16921958-16921959 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs139346000 | chr7:16921979-16921980 | Enhancers Weak transcription Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs568425624 | chr7:16922006-16922007 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs376911737 | chr7:16922007-16922008 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs533656494 | chr7:16922042-16922043 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs189240612 | chr7:16922050-16922051 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs181012097 | chr7:16922051-16922052 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs570733591 | chr7:16922132-16922133 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs575840176 | chr7:16922148-16922149 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs553409418 | chr7:16922156-16922157 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs185950444 | chr7:16922162-16922163 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs558688622 | chr7:16922165-16922166 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs577023385 | chr7:16922190-16922191 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs201862139 | chr7:16922198-16922199 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs150073299 | chr7:16922216-16922217 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs556622472 | chr7:16922245-16922246 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs148785143 | chr7:16922246-16922247 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs9648222 | chr7:16922249-16922250 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 22495309 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:16918000-16921600 | Active TSS | Duodenum Mucosa | Duodenum |
2 | chr7:16918200-16922000 | Active TSS | Rectal Mucosa Donor 29 | rectum |
3 | chr7:16918400-16922000 | Active TSS | Fetal Intestine Large | intestine |
4 | chr7:16918600-16922000 | Active TSS | Fetal Intestine Small | intestine |
5 | chr7:16919000-16922000 | Active TSS | Rectal Mucosa Donor 31 | rectum |
6 | chr7:16920000-16921800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr7:16920200-16921400 | Active TSS | Fetal Stomach | stomach |
8 | chr7:16920200-16921400 | Active TSS | Placenta Amnion | Placenta Amnion |
9 | chr7:16920600-16923000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr7:16920800-16921800 | Weak transcription | Stomach Mucosa | stomach |
11 | chr7:16921000-16922200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr7:16921400-16922600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr7:16921600-16922200 | Weak transcription | Duodenum Mucosa | Duodenum |
14 | chr7:16921800-16922200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
15 | chr7:16921800-16923600 | Enhancers | Stomach Mucosa | stomach |
16 | chr7:16922000-16922200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
17 | chr7:16922000-16922600 | Enhancers | Fetal Intestine Large | intestine |
18 | chr7:16922000-16923000 | Enhancers | Fetal Intestine Small | intestine |
19 | chr7:16922000-16931600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
20 | chr7:16922200-16922600 | Enhancers | Duodenum Mucosa | Duodenum |
21 | chr7:16922200-16922600 | Enhancers | Rectal Mucosa Donor 29 | rectum |
22 | chr7:16922200-16923200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |